WaveBot: The Automated Trading Tool for This Bull Market

The 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But here’s the thing: most people won’t be able to keep up with the pace of the market. That’s why I want to tell you about WaveBot – an automated trading tool created by my good friends Joel and Adam.

Raymond G. Murphy net worth and biography

Raymond Murphy Biography and Net Worth

Director of Integra LifeSciences

RAYMOND G. MURPHY has been a director since 2009.

Mr. Murphy was formerly senior vice president and treasurer of Time Warner, Inc., responsible for all U.S. and international corporate finance, project (real estate and film) finance, cash management, foreign exchange and interest rate risk management, public debt and equity financing, real estate financing, securitization financing, banking relationships and financings, and relationships with rating agencies, as well as corporate wide real estate activities and the property/casualty risk management program. Prior to joining Time Warner, Mr. Murphy held a variety of executive leadership roles, including senior vice president and treasurer at America Online, Inc., senior vice president for finance and treasurer at Marriott International, Inc. He also held executive positions at Manor Care, Inc., Ryder System Inc. and W R Grace & Company.

Mr. Murphy was a member of the finance committee of the Advertising Council Inc. and was the chair of the committee from 2007 until 2009. He was a member of the Board of Directors of the Advertising Council, Inc. in 2004 and served on its executive committee.

Mr. Murphy received a B.S. from Villanova University and an M.B.A. from Columbia University Graduate School of Business.

What is Raymond G. Murphy's net worth?: The estimated net worth of Raymond G. Murphy is at least $996,538.25 as of August 5th, 2022. Mr. Murphy owns 40,825 shares of Integra LifeSciences stock worth more than $996,538 as of December 3rd. This net worth estimate does not reflect any other assets that Mr. Murphy may own. Learn More about Raymond G. Murphy's net worth.
How do I contact Raymond G. Murphy?: The corporate mailing address for Mr. Murphy and other Integra LifeSciences executives is 311 ENTERPRISE DRIVE, PLAINSBORO NJ, 08536. Integra LifeSciences can also be reached via phone at (609) 275-0500 and via email at [email protected]. Learn More on Raymond G. Murphy's contact information.
Has Raymond G. Murphy been buying or selling shares of Integra LifeSciences?: Raymond G. Murphy has not been actively trading shares of Integra LifeSciences within the last three months. Most recently, Raymond G. Murphy sold 8,000 shares of the business's stock in a transaction on Friday, August 5th. The shares were sold at an average price of $55.78, for a transaction totalling $446,240.00. Following the completion of the sale, the director now directly owns 40,825 shares of the company's stock, valued at $2,277,218.50. Learn More on Raymond G. Murphy's trading history.
Who are Integra LifeSciences' active insiders?: Integra LifeSciences' insider roster includes Richard Caruso (Major Shareholder), Glenn Coleman (COO), Jan De Witte (CEO), Stuart Essig (Director), Lisa Evoli (EVP), Michael McBreen (EVP), Jeffrey Mosebrook (SVP), Raymond Murphy (Director), and Eric Schwartz (EVP). Learn More on Integra LifeSciences' active insiders.
Are insiders buying or selling shares of Integra LifeSciences?: In the last year, Integra LifeSciences insiders bought shares 1 times. They purchased a total of 52,641 shares worth more than $1,499,742.09. The most recent insider tranaction occured on May, 23rd when Chairman Stuart Essig bought 52,641 shares worth more than $1,499,742.09. Insiders at Integra LifeSciences own 3.1% of the company. Learn More about insider trades at Integra LifeSciences.
Information on this page was last updated on 5/23/2024.

Raymond G. Murphy Insider Trading History at Integra LifeSciences

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/5/2022	Sell	8,000	$55.78	$446,240.00	40,825
8/16/2019	Sell	4,136	$60.99	$252,254.64	41,026
8/23/2016	Sell	2,600	$86.64	$225,264.00	33,047
8/4/2016	Sell	2,610	$84.83	$221,406.30	33,057

Raymond G. Murphy Buying and Selling Activity at Integra LifeSciences

Integra LifeSciences Company Overview

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.

Today's Range

Now: $24.41

$24.15

$24.79

50 Day Range

MA: $20.92

$16.95

$26.70

2 Week Range

Now: $24.41

$16.81

$45.42

Volume

67,309 shs

Average Volume

1,082,410 shs

Market Capitalization

$1.88 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.15